Regenerex Pharma Enters Material Definitive Agreement

Ticker: RGPX · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1357878

Regenerex Pharma, Inc. 8-K Filing Summary
FieldDetail
CompanyRegenerex Pharma, Inc. (RGPX)
Form Type8-K
Filed DateJul 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, corporate-action

TL;DR

Regenerex Pharma just signed a big deal, filing an 8-K on 7/31/25.

AI Summary

On July 31, 2025, Regenerex Pharma, Inc. entered into a material definitive agreement. The company, formerly known as Peptide Technologies, Inc. and Eternelle Skincare Products Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing indicates a significant new contract or partnership for Regenerex Pharma, which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement is a significant event, but the lack of specific details in this initial filing warrants a medium risk assessment.

Key Players & Entities

  • REGENEREX PHARMA, INC (company) — Registrant
  • July 31, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of Incorporation
  • PEPTIDE TECHNOLOGIES, INC. (company) — Former Company Name
  • Eternelle Skincare Products Inc. (company) — Former Company Name
  • 5348 Vegas Drive #177 Las Vegas , NV 89108 (address) — Business Address

FAQ

What is the nature of the material definitive agreement entered into by Regenerex Pharma, Inc.?

The filing states that Regenerex Pharma, Inc. entered into a material definitive agreement on July 31, 2025, but does not provide specific details about the agreement's nature in the provided text.

When was the material definitive agreement entered into?

The material definitive agreement was entered into on July 31, 2025.

What was Regenerex Pharma, Inc. formerly known as?

Regenerex Pharma, Inc. was formerly known as PEPTIDE TECHNOLOGIES, INC. and Eternelle Skincare Products Inc.

In which state is Regenerex Pharma, Inc. incorporated?

Regenerex Pharma, Inc. is incorporated in Nevada.

What is the business address of Regenerex Pharma, Inc.?

The business address of Regenerex Pharma, Inc. is 5348 Vegas Drive #177, Las Vegas, NV 89108.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding REGENEREX PHARMA, INC. (RGPX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.